RELAXO

Relaxo Footwears Share Price

₹560.15 -14.45 (-2.51%)

22 Jan, 2025 12:17

SIP TrendupStart SIP in RELAXO

Start SIP

Performance

  • Low
  • ₹560
  • High
  • ₹575
  • 52 Week Low
  • ₹560
  • 52 Week High
  • ₹949
  • Open Price₹575
  • Previous Close₹575
  • Volume31,672

Investment Returns

  • Over 1 Month -10.65%
  • Over 3 Month -27.79%
  • Over 6 Month -31.71%
  • Over 1 Year -35.53%
SIP Lightning

Smart Investing Starts Here Start SIP with Relaxo Footwears for Steady Growth!

Invest Now

Relaxo Footwears Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 77
  • PEG Ratio
  • -11.6
  • Market Cap Cr
  • 13,944
  • P/B Ratio
  • 6.9
  • Average True Range
  • 14.29
  • EPS
  • 7.27
  • Dividend Yield
  • 0.5
  • MACD Signal
  • -19.47
  • RSI
  • 24.24
  • MFI
  • 36.92

Relaxo Footwears Financials

Relaxo Footwears Technicals

EMA & SMA

Current Price
₹560.15
-14.45 (-2.51%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹603.63
  • 50 Day
  • ₹644.83
  • 100 Day
  • ₹695.21
  • 200 Day
  • ₹750.84

Resistance and Support

575.6 Pivot Speed
  • R3 590.40
  • R2 585.80
  • R1 580.20
  • S1 570.00
  • S2 565.40
  • S3 559.80

What's your outlook on Relaxo Footwears?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Relaxo Footwears is India’s leading footwear manufacturer, offering a wide range of affordable and stylish footwear under popular brands like Sparx, Flite, and Bahamas. It produces over 20 crore pairs annually, catering to diverse customer needs nationwide.

Relaxo Footwears has an operating revenue of Rs. 2,887.48 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 9% is okay, ROE of 10% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 33 which is a POOR score indicating inconsistency in earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 145 indicates it belongs to a poor industry group of Apparel-Shoes & Rel Mfg and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Relaxo Footwears Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-08 Quarterly Results
2024-07-31 Quarterly Results
2024-05-09 Audited Results & Final Dividend
2024-01-31 Quarterly Results
2023-11-01 Quarterly Results
Date Purpose Remarks
2024-08-22 FINAL Rs.3.00 per share(300%)Final Dividend
2022-08-18 FINAL Rs.2.50 per share(250%)Final Dividend
View More

Relaxo Footwears F&O

Relaxo Footwears Shareholding Pattern

71.27%
9.96%
0%
3.41%
5.14%
10.22%

About Relaxo Footwears

  • NSE Symbol
  • RELAXO
  • BSE Symbol
  • 530517
  • Chairman & Managing Director
  • Mr. Ramesh Kumar Dua
  • ISIN
  • INE131B01039

Similar Stocks to Relaxo Footwears

Relaxo Footwears FAQs

Relaxo Footwears share price is ₹560 As on 22 January, 2025 | 12:03

The Market Cap of Relaxo Footwears is ₹13944.3 Cr As on 22 January, 2025 | 12:03

The P/E ratio of Relaxo Footwears is 77 As on 22 January, 2025 | 12:03

The PB ratio of Relaxo Footwears is 6.9 As on 22 January, 2025 | 12:03

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23